Cancer-treatment developer CG Oncology files for IPO

Bladder-cancer treatment developer CG Oncology filed for an initial public offering with the Securities and Exchange Commission.

Previous post These 3 flashpoints could spark a wider Middle East war that markets can’t ignore
Next post BrightSpring Health Services files for IPO